Octave Specialty Group Inc (OSG)

Total Liabilities

$1.27B

Quarterly · Period ending: · USD

OSG logo

OSG Total Liabilities

Latest reported$1.27B
OSG Quarterly Total Liabilities ($684.40M → $1.27B)
High-resolution chart · PNG

OSG total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Octave Specialty Group Inc Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
1,265,483,000
1,237,483,000
1,137,151,000
1,000,469,000
7,303,678,000
7,041,817,000
6,862,857,000
7,382,000,000
6,748,000,000
6,994,000,000
6,996,627,000
6,507,000,000
6,809,000,000
6,892,000,000
6,648,000,000
8,323,000,000
9,197,000,000
10,539,000,000
11,187,000,000
11,087,000,000
11,764,000,000
11,697,000,000
12,073,000,000
11,717,000,000
11,632,000,000
11,715,000,000
11,783,000,000
11,822,440,000
13,160,150,000
13,357,011,000
12,955,564,000
13,294,655,000
19,471,302,000
20,738,801,000
21,547,116,000
21,520,446,000
21,067,230,000
20,874,644,000
20,657,678,000
21,839,255,000
21,136,274,000
21,706,960,000
21,769,724,000
22,637,882,000
23,466,425,000
23,548,889,000
23,486,129,000
25,340,095,000
26,499,822,000
25,885,437,000
26,128,517,000
27,746,888,000
26,913,300,000
29,034,730,000
30,254,131,000
30,435,405,000
30,367,170,000
30,286,526,000
30,263,228,000
29,807,158,000
30,014,410,000
29,504,201,000
30,401,341,000
32,545,819,000
31,478,464,000
37,292,462,000
20,520,012,000
20,273,597,000
24,659,379,000
23,367,864,000
20,338,707,000
21,319,628,000
20,935,612,000
23,633,524,000
21,285,118,000
16,331,179,000
15,019,912,000
14,122,681,000
14,083,624,000
15,005,374,000
14,643,549,000
14,261,495,000
14,352,933,000
13,868,306,000
14,236,850,000
13,512,548,000
13,560,801,000
12,183,579,000
12,387,293,000
12,927,920,000
12,492,756,000
12,255,148,000
12,755,797,000
12,581,430,000
11,730,359,000
11,067,955,000
10,508,265,000
9,779,529,000
9,284,007,000
8,446,561,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.